medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Número 2

<< Anterior

Ann Hepatol 2013; 12 (2)


Cirrhosis is less cirrhosis without virus C

Llorca R, Funuyet J, Romero-Gómez M

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 341-342
Archivo PDF: 61.53 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Van der Meer AJ, Veldt BJ, Feld JJ, Wedemaeier H, Dufour JF, Lammert F, Duarte-Rojo A, et al. Association between sustained virological response and all-cause mortality among patient with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308: 2584-93.

  2. Pol S, Carnot F, Nalpas B, Lagneau JL, Fontaine H, Serpaggi J, Serfaty L, et al. Reversibility of hepatitis C virus-related cirrhosis. Hum Pathol 2004; 35: 107-12.

  3. Hernandez R. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. World J Gastroenterol 2012; 18: 4145-9.

  4. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-80.

  5. Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I, Ganne-Carrie N, et al. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab 2011; 96: 2601-8.

  6. Qin L, Wang Y, Tao L, Wang Z. AKT down-regulates insulinlike growth factor-1 receptor as a negative feedback. J Biochem 2011; 150: 151-6.

  7. Siddique A, Kowdley KV. Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma. Clin Liver Dis 2011; 15: 281-96.

  8. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012; 24: 981-90.

  9. Donadon V, Balbi M, Mas MD, Casarin P, Zanette G. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int 2010; 30: 750-8.

  10. Lisa B, Wagner V, Rinella M. The role of insulin-sensitizing agents in the treatment of non alcoholic steatohepatitis. Ther Adv Gastroenterol 2011; 4: 249-63.

  11. Guo L, Xie B, Mao Z. Autophagy in Premature Senescent Cells Is Activated via AMPK Pathway. Int J Mol Sci 2012; 13: 3563-82.

  12. Zajkowicz A, Rusin M. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases. Mech Ageing Dev 2011; 132: 543-51.

  13. Razavi H. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology 2013 [In press].




2020     |     www.medigraphic.com